Pnc Financial Services Group, Inc. Sage Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 532 shares of SAGE stock, worth $3,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares

532

Previous 717 25.8%

Holding current value

$3,473

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$5.55 - $8.66 $1,026 - $1,602	-185 Reduced 25.8%	532 $4,000
Q4 2024 Feb 07, 2025	SELL	$4.78 - $8.57 $764 - $1,371	-160 Reduced 18.24%	717 $3,000
Q3 2024 Nov 08, 2024	BUY	$7.02 - $13.08 $3,481 - $6,487	496 Added 130.18%	877 $6,000
Q2 2024 Aug 09, 2024	SELL	$10.58 - $17.9 $3,671 - $6,211	-347 Reduced 47.66%	381 $4,000
Q1 2024 May 10, 2024	SELL	$18.62 - $26.95 $4,655 - $6,737	-250 Reduced 25.56%	728 $13,000
Q4 2023 Feb 09, 2024	SELL	$17.1 - $22.26 $393 - $511	-23 Reduced 2.3%	978 $21,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $10,569 - $30,906	631 Added 170.54%	1,001 $20,000
Q2 2023 Aug 11, 2023	BUY	$40.65 - $59.54 $284 - $416	7 Added 1.93%	370 $17,000
Q3 2022 Nov 10, 2022	SELL	$32.28 - $43.27 $484 - $649	-15 Reduced 3.97%	363 $14,000
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $8,531 - $11,776	-310 Reduced 45.06%	378 $12,000
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $4,575 - $6,810	-149 Reduced 17.8%	688 $22,000
Q4 2021 Feb 11, 2022	BUY	$37.06 - $47.11 $3,224 - $4,098	87 Added 11.6%	837 $35,000
Q3 2021 Nov 05, 2021	SELL	$40.26 - $57.37 $12,400 - $17,669	-308 Reduced 29.11%	750 $33,000
Q2 2021 Aug 06, 2021	SELL	$54.88 - $79.29 $603 - $872	-11 Reduced 1.03%	1,058 $60,000
Q1 2021 May 07, 2021	BUY	$70.65 - $96.76 $14,907 - $20,416	211 Added 24.59%	1,069 $80,000
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $2,862 - $4,363	49 Added 6.06%	858 $74,000
Q3 2020 Nov 06, 2020	BUY	$41.13 - $62.45 $2,344 - $3,559	57 Added 7.58%	809 $49,000
Q2 2020 Aug 07, 2020	BUY	$25.95 - $43.15 $51 - $86	2 Added 0.27%	752 $31,000
Q1 2020 May 08, 2020	BUY	$26.15 - $77.24 $10,852 - $32,054	415 Added 123.88%	750 $21,000
Q4 2019 Feb 07, 2020	SELL	$60.18 - $154.77 $21,724 - $55,871	-361 Reduced 51.87%	335 $24,000
Q3 2019 Nov 08, 2019	BUY	$140.29 - $189.96 $37,317 - $50,529	266 Added 61.86%	696 $97,000
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $18,152 - $21,055	-115 Reduced 21.1%	430 $0
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $44,754 - $81,988	501 Added 1138.64%	545 $0
Q4 2018 Feb 08, 2019	SELL	$81.94 - $139.71 $1,556 - $2,654	-19 Reduced 30.16%	44 $4,000
Q3 2018 Nov 09, 2018	BUY	$138.11 - $169.04 $3,452 - $4,226	25 Added 65.79%	63 $0
Q2 2018 Aug 10, 2018	BUY	$140.36 - $175.76 $1,965 - $2,460	14 Added 58.33%	38 $0
Q1 2018 May 11, 2018	BUY	$152.15 - $192.33 $2,130 - $2,692	14 Added 140.0%	24 $0
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $607 - $1,673	10	10 $0

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

49.9M

Call Options Held

220K

Put Options Held

312K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $388M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Sage Therapeutics, Inc. Transaction History